The present invention relates to a new
compound A: [
Chemical formula should be inserted here. Please see paper copy] a process for its preparation, pharmaceutical formulations containing said therapeutically
active compound and to the use of said
active compound in therapy. The compound is an inhibitor of the
enzyme MPO and is thereby particularly useful in the treatment or prophylaxis of neuroinflammatory disorders, cardiovascular disorders and respiratory disorders.